Skip to main content
Sister Publication Links
  • ESG: THE NEW IMPERATIVE
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • Current News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Digital Health
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
  • Opinion
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Custom Media Event: ESG Summit
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Transformation Summit
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Supply Chain Revenue Cycle
    • - Hospital at Home
    • - Workplace of the Future
    • - Virtual Health
    • - Future of Healthcare Staffing
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Transformation Hub

Where healthcare challenges find solutions

  • Patients
  • Operations
  • Care Delivery
  • Payment
Operations
May 15, 2019 12:01 AM

Civica Rx partners with Xellia Pharmaceuticals on first generic drugs

Alex Kacik
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    Civica Rx teamed up with Xellia Pharmaceuticals to produce the antibiotics vancomycin and daptomycin for Civica's members, the companies announced Wednesday.

    The drugs used to treat critically ill patients with serious infections are the first that the hospital-led not-for-profit generic drug company have identified. Civica, bolstered by the support of more than 800 U.S. hospitals, plans to deliver 14 generic medications this year as it aims to reinforce the supply of generics prone to shortage and reduce drug costs.

    Vancomycin and daptomycin target bacteria that are resistant to other antibiotics, said Martin VanTrieste, CEO of Civica.

    "By helping to stabilize the supply of vancomycin and daptomycin, we will have a direct impact on patient safety and public health by providing consistent access to antibiotics that are important treatment options in the management of difficult-to-treat and life-threatening infections," he said in prepared remarks.

    For the initial phase, Civica Rx is working with holders of abbreviated new drug applications, or ANDAs, that have the manufacturing capability and capacity to produce antibiotics, anesthetics, cardiac medications, pain management medications and other essential sterile injectable medicines used in hospitals daily. Next, the organization plans to acquire or develop its own ANDAs and use contract manufacturers. Over the longer-term, Civica Rx plans to buy or build its own manufacturing facilities.

    Its member hospitals sign contracts of five to 10 years to facilitate lower prices Civica negotiates with manufacturers, the organization said.

    Chronic drug shortages impact nearly every provider, and the effects trickle down to the consumer. Finding new suppliers can lead to errors, safety issues or delayed surgeries as well as inflate costs.

    Generic drug competition has declined as companies consolidate. That coupled with manufacturing problems and natural disasters have led to severe shortages of widely used drugs.

    Many manufacturers have opted to make higher-margin drugs rather than generics. But those that still do have vast market power and can manipulate prices.

    "We've lost balance," Jeff Rosner, senior director of pharmacy contracting and purchasing at the Cleveland Clinic, said in January. "It's a lot more profitable to make a contracted drug for a branded company as opposed to making generic drugs."

    Providence St. Joseph Health, a Civica founding member, has been dealing with intermittent shortages of different presentations of vancomycin and daptomycin, said Dr. Amy Compton-Phillips, executive vice president and chief clinical officer. When these drugs aren't available in the right dose, clinicians have to adjust and the process becomes riskier, she said.

    "You are setting things up to fail," Compton-Phillips said.

    Many intravenous drugs are chronically short at PSJH hospitals, including vasopressors used to treat patients in septic shock and morphine, she said.

    While the irrational price hikes and supply-crippling natural disasters illustrate a broken generic drug market, the rationale behind Civica is starting to pay off as more stakeholders band together to fix it, Compton-Phillips said.

    "The shot across the bow helped reinvigorate a complacent industry," she said. "The crisis we have at the moment is affordability. We pushed back against these crazy rates of inflation in drug prices. We just cant do it. We have got to change the discussion so we're just not victims of circumstance. We will do it ourselves."

    Xellia will make medications for Civica under Xellia's abbreviated new drug application with Civica labeling.

    The collaboration supports Xellia's long-term goal of mitigating anti-infective drug shortages, CEO Carl-Aake Carlsson said in prepared remarks.

    Copenhagen-based Xellia, which is owned by Novo Holdings, is expanding its manufacturing and sales capacity within the U.S. as it looks to boost transparency on production by making its own raw materials.

    The Danish company acquired the old Ben Venue Laboratories complex in Bedford, Ohio in 2015 that it's using as a packaging and distribution hub. Ben Venue closed the facility in 2011 following quality concerns outlined by the U.S. Food and Drug Administration.

    Tags: Operations, This Week in Healthcare, Generic drugs, Transformation Hub, Operations, Transformation
    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    HCA Healthcare sign
    HCA, J&J strike wide-ranging partnership
    The Check Up: Dr. Alex Jahangir of Vanderbilt Medical Center
    The Check Up: Dr. Alex Jahangir of Vanderbilt Medical Center
    Sponsored Content
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Digital Health
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Opinion
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top 25 Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Transformation Summit
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Supply Chain Revenue Cycle
        • - Hospital at Home
        • - Workplace of the Future
        • - Virtual Health
        • - Future of Healthcare Staffing
      • Custom Media Event: ESG Summit
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing